Cellebrite has appointed Shiv Ramji as Chief Executive Officer effective today, succeeding Tom Hogan, and simultaneously lowered its full-year 2026 ARR and revenue guidance while raising its adjusted EBITDA target. The company reported second-quarter ARR of $508 million, up 21% year-over-year but below the bottom end of its guidance range, and revenue of $131 million, up 16%. Cellebrite now expects full-year ARR of $550 million to $560 million, a reduction of $15 million at the midpoint, and revenue of $555 million to $561 million, representing growth of 17% to 18%. The company attributed the shortfall to delayed large transactions, new administrative and procurement requirements tied to its foreign entity status, and lower-than-expected ARR uplift from Insights conversions, particularly in U.S. state and local government. Cellebrite raised its full-year adjusted EBITDA target to $153 million to $159 million, a 28% margin, and reported second-quarter adjusted EBITDA of $31.8 million.
Cellebrite DICellebrite lowered its full-year 2026 ARR and revenue guidance, citing delayed transactions and lower-than-expected conversions, despite raising EBITDA target.
